https://twitter.com/hswapnil/status/1737886439335927980I will start with: - Renal denervation finally approved in the USA (both Medtronic and Otsuka/ReCor) - Endothelin antagonists advance (PROTECT/DUPLEX/PRECISION/ZENITH) - Inaxaplin in APOL1 - Freely Filtered simul-broadcast with @AmitXGarg #KidneyWk #TopNephrology nominations
— Swapnil Hiremath @hswapnil@med-mastodon.com (@hswapnil) Dec 21, 2023
No comments:
Post a Comment